Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Technology Advances: CISH technology Facilitates Assay of HER2 Expression
Dorothy J. Schirf, MD, MDLinx Oncology
Today's Oncology News: VEGFb Designated Orphan Drug Status By FDA
D Scott Cunningham MD, PhD, MDLinx Oncology
  See all
neuroblastoma;chromosome 6p22 Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma
New England Journal of Medicine, 05/15/08
Print     Email This Article     Save in My Library   Free Abstract
Maris JM et al. – A common genetic variation at chromosome band 6p22 is associated with susceptibility to neuroblastoma

Methods

  • Genome-wide association study by genotyping blood DNA samples from 1,032 neuroblastoma pts and 2043 controls, using Illumina HumanHap550 BeadChip
  • Samples from 3 independent neuroblastoma pt grps (total 720 pts) and 2128 controls then genotyped to replicate significant associations

Results
  • Significant association between neuroblastoma and common minor alleles of 3 consecutive single-nucleotide polymorphisms (SNPs) at chromosome band 6p22 and containing predicted genes FLJ22536 and FLJ44180
  • Homozygosity for the at-risk G allele of the most significantly associated SNP, rs6939340, increased likelihood of neuroblastoma
  • Subsequent genotyping of 3 6p22 SNPs in 3 independent case series confirmed this association
  • Neuroblastoma pts homozygous for risk alleles at 6p22 were more likely to have metastatic (stage 4) disease, amplification of the MYCN oncogene in the tumor cells, and disease relapse

 

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

Sponsor
--- NEUROLOGIC ONCOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.